Skip to main content

About RSP Systems A/S

RSP Systems A/S is dedicated to improving the health and quality of life of people worldwide through its unique and patented solution for non-invasive diagnostics. The first targeted application is a product line of non-invasive glucose monitors, which will provide diabetics with a convenient, pain-free alternative to the current invasive solutions, which require finger pricking to extract blood onto an expensive test strip. Self-monitoring of glucose is a key element in efficient diabetes management and constitutes a global market exceeding USD 10 billion annually. Other potential applications include the measurement of alcohol and lactate.

RSP’s technology is based on a direct optical detection principle, Raman spectroscopy, a mature technology to which RSP has developed and patented improvements enabling the measurement of concentrations of various substances in the interstitial fluid (tissue fluid surrounding the cells of the body) non-invasively through the skin. Proof-of-concept for glucose monitoring in diabetics has been demonstrated through pilot trials in collaboration with Odense University Hospital in Denmark.

RSP Systems A/S was founded in 2006 as a spin-out from the Biophotonics Group at the University of Southern Denmark (SDU). Today, the company employs a small organization and leverages its resources by partly outsourcing its development activities to an established network of suppliers and partners in Europe, North America, and Asia.

For more information, please visit www.rspsystems.com